Biopure
11 Hurley St
Cambridge
MA
02141
United States
(617) 234-6500
Product(s):
Develops, manufactures and markets hemoglobin-based oxygen therapeutic products
Ownership:
Public
Exchange:
NSDQ
symbol:
BPUR
2004 Revenue:
$3,750,000
2005 Revenue:
$2,110,000
2006 Revenue:
$1,715,000
2007 Revenue:
$2,556,000
2008 Revenue:
$3,128,000
Yahoo Quotes:
Chairman:
Zafiris G. Zafirelis
President:
Zafiris G. Zafirelis
CEO:
Zafiris G. Zafirelis Management:
David A. Butler, interim CFO
Jane Kober, SVP, general counsel, secretary
Geoffrey J. Filbey, VP-engineering
A. Gerson Greenburg, VP-medical Affairs
W. Richard Light, VP-technology development
Virginia T. Rentko, VP-preclinical development
Barry L. Scott, VP-business development
Biopure
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
